Trade ATRC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
AtriCure, Inc. (ATRC) is trading at US$58.10, down 1.73% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$2.49B. Over the past 52 weeks, ATRC has traded between US$25.36 and US$59.88. On Syfe you can trade ATRC with $0 commission and add it to your watchlist.
| Previous close | US$59.12 |
|---|---|
| Market cap | US$2.49B |
| P/E ratio | 175.24 |
| 52-week range | US$25.36 – US$59.88 |
| Volume | 8.63M |
| Exchange | US |
Add to Watchlist
Set Price Alert
AtriCure, Inc.
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Year: 2005
Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing
Jul 30, 9:04 PM · MT Newswires
UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating
Jul 28, 2:20 PM · MT Newswires
AtriCure, Inc. (ATRC) stock is trading at US$58.10, -1.73% from the previous close of US$59.12.
The market cap for AtriCure, Inc. (ATRC) stock is approximately US$2.49B.
The price-to-earnings ratio for AtriCure, Inc. (ATRC) is 175.24, based on the latest reported earnings.
The 52-week high for AtriCure, Inc. (ATRC) stock is US$59.88.
The 52-week low for AtriCure, Inc. (ATRC) stock is US$25.36.
AtriCure, Inc. (ATRC) does not currently pay a dividend.
Stay on top of ATRC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
